In contrast, these secondary genetic abnormalities are rare in IDH wild-type gliomas, while EGFR amplification appears to occur more frequently compared with IDH mutant gliomas (Figure 1B) [1,43]. The gene discussed is IDH1; the disease is central nervous system cancer.